Schedule 13G ownership disclosure

INSYS THERAPEUTICS INC

Security class unavailable · CUSIP: 45824V209

Event date: 2019-04-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,920,536
Percent of class
9.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001615774-19-006507
Form type
SC 13G/A
Filer
ETF MANAGERS GROUP, LLC
CIK
CIK 1645173
Filed
Apr 29, 2019
Reporting period
Apr 26, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub